EGF regulates claudin-2 and -4 expression through Src and STAT3 in MDCK cells

J Cell Physiol. 2015 Jan;230(1):105-15. doi: 10.1002/jcp.24687.

Abstract

Epidermal Growth Factor (EGF) is a key regulator of epithelial paracellular permeability, a property that depends on tight junctions (TJ) and can be evaluated through the measurement of the transepithelial electrical resistance (TER). EGF increases the TER of MDCK monolayers by inducing ERK1/2-dependent downregulation of claudin-2 (CLDN-2) and upregulation of claudin-4 (CLDN-4). Because either increments or decrements in TER often involve Src activation and epithelial cell differentiation occasionally depends on STAT3, here we investigated whether EGF might control CLDN-2 downregulation and CLDN-4 upregulation through those proteins. We found that EGF induces Src activation necessary for the reduction of CLDN-2 at the TJ, the degradation of this CLDN, the reduction of the cellular levels of its mRNA and the resulting increase of TER. EGF-induced changes on CLDN-2 protein and mRNA also depend on STAT3 activity. This growth factor increases the levels of STAT3 phosphorylated at Y705 in the nucleus, a process that depends on Src activation. Interestingly, Src and STAT3 activation do not exclusively mediate the EGF-induced downregulation of CLDN-2, but they are also implicated in the EGF-induced CLDN-4 transcription, translation, and exocytic fusion into TJ. Our results indicate that EGF controls the levels of CLDN-2 and -4 proteins and mRNAs through Src and STAT3 activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Butadienes / pharmacology
  • Claudin-2 / biosynthesis*
  • Claudin-2 / genetics
  • Claudin-4 / biosynthesis*
  • Claudin-4 / genetics
  • Dogs
  • Down-Regulation
  • Electric Impedance
  • Enzyme Inhibitors / pharmacology
  • Epidermal Growth Factor / pharmacology
  • Epidermal Growth Factor / physiology*
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Indoles / pharmacology
  • Madin Darby Canine Kidney Cells
  • Maleimides / pharmacology
  • Nitriles / pharmacology
  • Phosphorylation
  • Protein Biosynthesis
  • Protein Kinase Inhibitors / pharmacology
  • Pyrimidines / pharmacology
  • RNA, Messenger / biosynthesis
  • STAT3 Transcription Factor / biosynthesis
  • STAT3 Transcription Factor / metabolism*
  • Tight Junctions / physiology
  • Transcription, Genetic
  • Up-Regulation
  • src-Family Kinases / antagonists & inhibitors
  • src-Family Kinases / biosynthesis
  • src-Family Kinases / metabolism*

Substances

  • 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide
  • AG 1879
  • Butadienes
  • Claudin-2
  • Claudin-4
  • Enzyme Inhibitors
  • Indoles
  • Maleimides
  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrimidines
  • RNA, Messenger
  • STAT3 Transcription Factor
  • U 0126
  • Epidermal Growth Factor
  • src-Family Kinases
  • Extracellular Signal-Regulated MAP Kinases